/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/
MONTREAL, Sept. 9, 2025 /CNW/ - ChitogenX Inc., (CNSX:CHGX.CN) (OTC-BB:CHNXF) ("ChitogenX" or the "Company"), today confirms that it has entered into a binding letter of intent (the "LOI") dated September 8, 2025 with Oligo Medic Inc. ("Oligo Medic"), a private Canadian biotechnology company, to pursue a potential reverse takeover ("RTO") transaction (the "Proposed Transaction").
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.